Organon OGN Acquired in-process research and development and milestones
Acquired in-process research and development and milestones at other companies
Other financials
Where this comes from
Reported directly by Organon in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationFairValueAcquired.
The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Organon's acquired in-process research and development and milestones.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Organon's acquired in-process research and development and milestones?
- Organon (OGN) reported acquired in-process research and development and milestones of $0 in Q1 2026.
- How has Organon's acquired in-process research and development and milestones changed year-over-year?
- Organon's acquired in-process research and development and milestones decreased by 100.0% year-over-year, from $6M to $0.
- What is the long-term trend for Organon's acquired in-process research and development and milestones?
- Over 3 years (2021 to 2025), Organon's acquired in-process research and development and milestones has grown at a -61.4% compound annual growth rate (CAGR), from $104M to $6M.
- What does acquired in-process research and development and milestones mean?
- Represents non-cash adjustments or specific operating-related expenditures associated with the acquisition of in-process research and development assets or milestone payments. This metric highlights the company's commitment to external innovation and pipeline expansion through strategic licensing or development agreements. It is a critical indicator of how the firm integrates external scientific advancements into its core operating activities.